Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer

NCT00222144 is registered in ClinicalTrials.gov with University of Kansas as lead sponsor.

NCT NCT00222144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer
Lead sponsor
University of Kansas
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
November 30, 2010
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer